Small-cap stock under ₹50 to be in focus on Monday. Details here (opens original article in a new tab)

Sudarshan Pharma's share capital increased after converting warrants into equity shares, boosting promoter holdings and share value. The stock has shown significant recent gains.

• Sudarshan Pharma's share capital increased to ₹24.96 crore after allotting 90 lakh equity shares from warrant conversions.
• Promoter shareholding rose to 58.93% following the conversion of 9 lakh warrants into 90 lakh equity shares.
• The company's share price has risen 22% in 1 month, 40% in 3 months, and 48% in 6 months.